FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration-Frattini et al
A-B) Nuclear preparations from BT165-NS were fixed with paraformaldehyde. After sonication, genomic DNA associated with FOXP3 was immune-precipitated and quantified by RT-PCR. The quantity of precipitated DNA was compared with the total input of genomic DNA, amplified by p21 and c-Myc specific primers. Primers mapping on telomeric regions were used as negative control (N2 primers). Non specific binding from control IgG ChIPs was subtracted and data were represented as percent input. Standard deviations from two experimental replicates are shown. NS were processed for qChIP as previously described [2] , with few modifications. Briefly, formaldehyde (37%) was added to the culture medium to a final concentration of 1%. Cross-linking was stopped by addition of glycine (0.125 M final concentration). Fixed cells were washed twice with PBS and harvested in SDS buffer (50 mM Tris pH 8.1, 0.5% SDS, 100 mM NaCl, 5 mM EDTA, and protease inhibitors). Cells were pelleted by centrifugation and resuspended in IP buffer (100 mM Tris pH 8.6, 0.3% SDS, 1.7% Triton X-100, and 5 mM EDTA). DNA fragments with a bulk size of 300-500 bp were obtained using a Branson digital sonifier 250 D. For each immuneprecipitation, 1 ml of diluted lysate (5x10 6 cells/ml) was pre-cleared using protein A beads (50% slurry protein A-Sepharose, Amersham) and immunoprecipitated overnight at 4°C with antibody specific for FOXP3 (ChIP grade antibody from Abcam, UK), in presence of 20ul of magnetic dynabeads. Beads were washed and crosslink was reversed in 1ml of water with 10% Chelex 100 (Bio-Rad, cat. no. 142-1253), and used directly for qPCR. PCR primer sequences: Microarray data Selection and accession numbers. Two microarray datasets were selected from microarray experiments performed with GeneChips Affymetrix HGU133Aplus 2.0 arrays (Dataset GSE4290; 105 samples -22 Normal Brain and 82 Glioblastomas) [3] and HGU133Aplus 2.0 arrays (Dataset GSE3526; 151 samples -18 regions of the central nervous system). All microarray data were available from the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress). Pre-processing microarray data. All arrays were tested for statistical quality controls provided by the array Quality Metrics Bioconductor package [4] : outlier samples were excluded from the analysis. This package allows users to perform a wide variety of data quality assessment approaches and to identify outlier arrays (i.e., arrays of low quality or very different from the whole dataset), in such a way to enhance statistical and biological significance of the analysis. The Robust Multichip Average (RMA) [5] algorithm was applied to normalize with quantile method and calculate probeset intensity. Normality of the distribution and homogeneity of variance in our datasets were tested using the Shapiro-Wilk and Bartlett's tests [6] . Differences of FOXP3 expression were studied with the t-test or Wilcoxon together with a false discovery rate correction of the p-value (Bonferroni correction). The corrected p-value threshold cut-off was less or equal to 0.05.
